Abstract: Despite the efforts of the global medical and scientific community, tuberculosis remains the leading cause of death from infectious diseases. The expectation of success associated with the development of new anti-TB drugs was not justified, and the attention of researchers was largely drawn to the creation of new mycobacterial strains for vaccination against tuberculosis. The proposed review contains current information on the existing vaccine strains and the development of new, genetically engineered strains for the prevention of tuberculosis and the prevention and treatment of other diseases. The review includes relevant information on the correlation between BCG vaccination and the frequency and severity of COVID-19 infection. ...
<p>Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidit...
It is almost 100 years since the development of bacille Calmette-Guérin (BCG), the only licensed vac...
There is an urgent need to develop more effective tuberculosis vaccines as chemotherapy and Bacille ...
Abstract: In this review we discuss recent progress in the development, testing, and clinical evalua...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin ...
Tuberculosis (TB) is now among the top ten causes of mortality worldwide being resulted in 1.7 milli...
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a...
<p><b>INTRODUCTION: </b>Apart from better diagnostics and new anti-microbial drugs...
An effective tuberculosis (TB) vaccine could have a significant impact on the current TB pandemic. T...
In this review we discuss recent progress in the development, testing, and clinical evaluation of ne...
Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...
Tuberculosis (TB) disease caused by Mycobacterium tuberculosis (M. tb) remains one of the leading in...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Exciting clinical results from 2 clinical TB vaccine trials were published in 2018. These, plus prom...
<p>Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidit...
It is almost 100 years since the development of bacille Calmette-Guérin (BCG), the only licensed vac...
There is an urgent need to develop more effective tuberculosis vaccines as chemotherapy and Bacille ...
Abstract: In this review we discuss recent progress in the development, testing, and clinical evalua...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin ...
Tuberculosis (TB) is now among the top ten causes of mortality worldwide being resulted in 1.7 milli...
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a...
<p><b>INTRODUCTION: </b>Apart from better diagnostics and new anti-microbial drugs...
An effective tuberculosis (TB) vaccine could have a significant impact on the current TB pandemic. T...
In this review we discuss recent progress in the development, testing, and clinical evaluation of ne...
Tuberculosis remains one of the most significant human diseases of the developing world, accounting ...
Tuberculosis (TB) disease caused by Mycobacterium tuberculosis (M. tb) remains one of the leading in...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Exciting clinical results from 2 clinical TB vaccine trials were published in 2018. These, plus prom...
<p>Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidit...
It is almost 100 years since the development of bacille Calmette-Guérin (BCG), the only licensed vac...
There is an urgent need to develop more effective tuberculosis vaccines as chemotherapy and Bacille ...